272 related articles for article (PubMed ID: 10385266)
1. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes.
Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM
J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
3. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts.
Leone RJ; Weiss HR; Scholz PM
J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations.
MacLeod KM; Diamond J
J Pharmacol Exp Ther; 1986 Jul; 238(1):313-8. PubMed ID: 3014120
[TBL] [Abstract][Full Text] [Related]
5. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy.
Roitstein A; Kedem J; Cheinberg B; Weiss HR; Tse J; Scholz PM
J Surg Res; 1994 Nov; 57(5):584-90. PubMed ID: 7967596
[TBL] [Abstract][Full Text] [Related]
6. Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure.
Zhang Q; Lazar M; Molino B; Rodriguez R; Davidov T; Su J; Tse J; Weiss HR; Scholz PM
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1251-7. PubMed ID: 16100251
[TBL] [Abstract][Full Text] [Related]
7. T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium.
Katz E; Zhang Q; Weiss HR; Scholz PM
Peptides; 2006 Sep; 27(9):2276-83. PubMed ID: 16762459
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cAMP metabolism in mouse parotid gland by cGMP and calcium.
Watson EL; Singh JC; McPhee C; Beavo J; Jacobson KL
Mol Pharmacol; 1990 Oct; 38(4):547-53. PubMed ID: 1700270
[TBL] [Abstract][Full Text] [Related]
9. Action of acetylcholine on regional myocardial work and metabolism in vivo: association with cyclic GMP.
Guo X; Kedem J; Scholz PM; Weiss HR
Can J Physiol Pharmacol; 1996 Jan; 74(1):73-9. PubMed ID: 8963954
[TBL] [Abstract][Full Text] [Related]
10. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
Simmons MA; Hartzell HC
Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
[TBL] [Abstract][Full Text] [Related]
11. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
Gong GX; Weiss HR; Tse J; Scholz PM
Eur J Pharmacol; 1998 Mar; 344(2-3):299-305. PubMed ID: 9600666
[TBL] [Abstract][Full Text] [Related]
12. Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP.
Moalem J; Weiss HR; Davidov T; Rodriguez R; Molino B; Lazar MJ; Scholz PM
J Surg Res; 2006 Aug; 134(2):300-6. PubMed ID: 16545395
[TBL] [Abstract][Full Text] [Related]
13. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
[TBL] [Abstract][Full Text] [Related]
14. Pacing-induced cardiac failure of hypertrophic hearts: effects of cyclic GMP reduction.
Huang MW; Weiss HR; Tse J; Leone RJ; Scholz PM
J Surg Res; 1999 Sep; 86(1):89-96. PubMed ID: 10452873
[TBL] [Abstract][Full Text] [Related]
15. Positive inotropy due to lowering cyclic GMP is also mediated by increases in cyclic AMP in control and hypertrophic hearts.
Naim KL; Rabindranauth P; Weiss HR; Tse J; Leone RJ; Scholz PM
Can J Physiol Pharmacol; 1998 Jun; 76(6):605-12. PubMed ID: 9923398
[TBL] [Abstract][Full Text] [Related]
16. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
Sadoff JD; Scholz PM; Tse J; Weiss HR
J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
[TBL] [Abstract][Full Text] [Related]
17. Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts.
Klabunde RE; Tse J; Weiss HR
Cardiovasc Res; 1998 Mar; 37(3):676-83. PubMed ID: 9659451
[TBL] [Abstract][Full Text] [Related]
18. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclic GMP and its protein kinase on the contraction of ventricular myocytes from hearts after cardiopulmonary arrest.
Su J; Scholz PM; Tse J; Weiss HR
Can J Physiol Pharmacol; 2004 Nov; 82(11):986-92. PubMed ID: 15644938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
